Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome)

Alka Aneja, Wanda P. Fremont, Kevin M. Antshel, Stephen V. Faraone, Nuria Abdulsabur, Anne Marie Higgins, Robert Shprintzen, Wendy R. Kates

    Research output: Contribution to journalArticle

    Abstract

    Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk factor for the eventual development of bipolar disorder in this population. Therefore, we sought to determine whether children with VCFS exhibit more manic symptoms than community controls that also may have learning disorders and ADHD. The study population consisted of 86 children with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania Rating Scale-Parent Version, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL), and Wechsler Intelligence Scale for Children-3rd edition (WISC-III). The results indicate that manic symptoms were not more prevalent in VCFS than in a community sample of children with learning disorders and ADHD. However, after accounting for symptoms of depression and ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Behavior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct problems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only. Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic symptoms suggest that these children may warrant more intensive monitoring and treatment relative to youth with VCFS and ADHD only.

    Original languageEnglish (US)
    Pages (from-to)105-114
    Number of pages10
    JournalJournal of Child and Adolescent Psychopharmacology
    Volume17
    Issue number1
    DOIs
    StatePublished - Feb 1 2007

    Fingerprint

    DiGeorge Syndrome
    Behavioral Symptoms
    Attention Deficit Disorder with Hyperactivity
    Bipolar Disorder
    Learning Disorders
    Child Behavior
    Checklist
    Wechsler Scales
    Mood Disorders
    Intelligence
    Population
    Schizophrenia
    Appointments and Schedules
    Anxiety
    Depression

    ASJC Scopus subject areas

    • Pharmacology (medical)
    • Psychiatry and Mental health
    • Pediatrics, Perinatology, and Child Health
    • Pharmacology, Toxicology and Pharmaceutics(all)

    Cite this

    Aneja, A., Fremont, W. P., Antshel, K. M., Faraone, S. V., Abdulsabur, N., Higgins, A. M., ... Kates, W. R. (2007). Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). Journal of Child and Adolescent Psychopharmacology, 17(1), 105-114. https://doi.org/10.1089/cap.2006.0023

    Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). / Aneja, Alka; Fremont, Wanda P.; Antshel, Kevin M.; Faraone, Stephen V.; Abdulsabur, Nuria; Higgins, Anne Marie; Shprintzen, Robert; Kates, Wendy R.

    In: Journal of Child and Adolescent Psychopharmacology, Vol. 17, No. 1, 01.02.2007, p. 105-114.

    Research output: Contribution to journalArticle

    Aneja, A, Fremont, WP, Antshel, KM, Faraone, SV, Abdulsabur, N, Higgins, AM, Shprintzen, R & Kates, WR 2007, 'Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome)', Journal of Child and Adolescent Psychopharmacology, vol. 17, no. 1, pp. 105-114. https://doi.org/10.1089/cap.2006.0023
    Aneja, Alka ; Fremont, Wanda P. ; Antshel, Kevin M. ; Faraone, Stephen V. ; Abdulsabur, Nuria ; Higgins, Anne Marie ; Shprintzen, Robert ; Kates, Wendy R. / Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). In: Journal of Child and Adolescent Psychopharmacology. 2007 ; Vol. 17, No. 1. pp. 105-114.
    @article{639344bd675548ebae85a9dd3bcaf5be,
    title = "Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome)",
    abstract = "Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk factor for the eventual development of bipolar disorder in this population. Therefore, we sought to determine whether children with VCFS exhibit more manic symptoms than community controls that also may have learning disorders and ADHD. The study population consisted of 86 children with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania Rating Scale-Parent Version, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL), and Wechsler Intelligence Scale for Children-3rd edition (WISC-III). The results indicate that manic symptoms were not more prevalent in VCFS than in a community sample of children with learning disorders and ADHD. However, after accounting for symptoms of depression and ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Behavior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct problems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only. Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic symptoms suggest that these children may warrant more intensive monitoring and treatment relative to youth with VCFS and ADHD only.",
    author = "Alka Aneja and Fremont, {Wanda P.} and Antshel, {Kevin M.} and Faraone, {Stephen V.} and Nuria Abdulsabur and Higgins, {Anne Marie} and Robert Shprintzen and Kates, {Wendy R.}",
    year = "2007",
    month = "2",
    day = "1",
    doi = "10.1089/cap.2006.0023",
    language = "English (US)",
    volume = "17",
    pages = "105--114",
    journal = "Journal of Child and Adolescent Psychopharmacology",
    issn = "1044-5463",
    publisher = "Mary Ann Liebert Inc.",
    number = "1",

    }

    TY - JOUR

    T1 - Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome)

    AU - Aneja, Alka

    AU - Fremont, Wanda P.

    AU - Antshel, Kevin M.

    AU - Faraone, Stephen V.

    AU - Abdulsabur, Nuria

    AU - Higgins, Anne Marie

    AU - Shprintzen, Robert

    AU - Kates, Wendy R.

    PY - 2007/2/1

    Y1 - 2007/2/1

    N2 - Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk factor for the eventual development of bipolar disorder in this population. Therefore, we sought to determine whether children with VCFS exhibit more manic symptoms than community controls that also may have learning disorders and ADHD. The study population consisted of 86 children with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania Rating Scale-Parent Version, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL), and Wechsler Intelligence Scale for Children-3rd edition (WISC-III). The results indicate that manic symptoms were not more prevalent in VCFS than in a community sample of children with learning disorders and ADHD. However, after accounting for symptoms of depression and ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Behavior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct problems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only. Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic symptoms suggest that these children may warrant more intensive monitoring and treatment relative to youth with VCFS and ADHD only.

    AB - Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk factor for the eventual development of bipolar disorder in this population. Therefore, we sought to determine whether children with VCFS exhibit more manic symptoms than community controls that also may have learning disorders and ADHD. The study population consisted of 86 children with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania Rating Scale-Parent Version, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL), and Wechsler Intelligence Scale for Children-3rd edition (WISC-III). The results indicate that manic symptoms were not more prevalent in VCFS than in a community sample of children with learning disorders and ADHD. However, after accounting for symptoms of depression and ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Behavior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct problems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only. Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic symptoms suggest that these children may warrant more intensive monitoring and treatment relative to youth with VCFS and ADHD only.

    UR - http://www.scopus.com/inward/record.url?scp=33947357128&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33947357128&partnerID=8YFLogxK

    U2 - 10.1089/cap.2006.0023

    DO - 10.1089/cap.2006.0023

    M3 - Article

    VL - 17

    SP - 105

    EP - 114

    JO - Journal of Child and Adolescent Psychopharmacology

    JF - Journal of Child and Adolescent Psychopharmacology

    SN - 1044-5463

    IS - 1

    ER -